The FDA has approved a new medication to slow Alzheimer's.

Published Date: 08 Jul 2023

Today, the FDA approved a new treatment for early-stage Alzheimer's disease that seems to only slightly slow the disease's progression. More than 6.5 million Americans are thought to be affected by this illness.

Read Full News

Latest News

ESC 2026: Clinical Trials That Could Change Practice

Which ESC 2026 trials matter most? An expert preview singles out the studies most likely to open new therapeutic avenues or challenge current practice.

Microbiome ‘Leak’ From Mouth to Gut Can Flag GI Cancer

Scientists identify a ‘microbial transmission’ signature — oral bacteria colonizing the gut — that flags gastrointestinal cancers with greater accuracy than conventional stool testing.

Nurse Practitioners the Key to Diagnosing Ketamine Cystitis

Ketamine cystitis causes irreversible damage but is often caught too late.

Key Clinical Challenges in Diverticulitis: New ACG Guideline

A new ACG guideline on the management of colonic diverticulitis provides recommendations on key issues including use of antibiotics and diet.

Unpartnered Status Tied to Low Binge Drinking Risk in Women

Being unpartnered in later life is linked to higher odds of alcohol abstinence among older adults and lower odds of binge drinking among women, without mediation by depression or loneliness.

Chemo Drug Exposure Linked to CAR T-Cell Therapy Outcomes

Optimal fludarabine exposure during lymphodepletion is associated with improved progression-free survival after CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma.

Todays Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

Todays Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

Latest News

Which ESC 2026 trials matter most? An expert preview singles out the studies most likely to open new therapeutic avenues or challenge current practice.

Scientists identify a ‘microbial transmission’ signature — oral bacteria colonizing the gut — that flags gastrointestinal cancers with greater accuracy than conventional stool testing.

Ketamine cystitis causes irreversible damage but is often caught too late.

A new ACG guideline on the management of colonic diverticulitis provides recommendations on key issues including use of antibiotics and diet.

Being unpartnered in later life is linked to higher odds of alcohol abstinence among older adults and lower odds of binge drinking among women, without mediation by depression or loneliness.

Optimal fludarabine exposure during lymphodepletion is associated with improved progression-free survival after CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma.

News All Time

Higher Body Fat Tied to Lower Kidney Function in Adults

Higher body and fat mass are associated with lower kidney function, particularly in women and adults older than 40 years, whereas greater fat-free mass is linked to better eGFR.

Youth Mental Health Model Shifts Care to Community Settings

A multiservice model that also supports youth with complex mental health needs shows that an inclusive approach offers a return on investment.

Poor Mental Health Tied to Risk for Drug Use Disorder

Poor mental health in US adults is linked to a significantly higher risk for a drug use disorder, with patterns often shaped by ADHD status, new research shows.

Active Surveillance Rises as Focal Therapy Persists

Surveillance has surged for favorable-risk prostate cancer, but focal therapy remains in use despite limited evidence and limited guideline support.

Ankle Strength Not Linked to Joint Hypermobility in Children

Ankle strength shows no clear association with foot posture or general joint hypermobility in children, with only weak links to lower limb hypermobility.

Symptoms May Signal Prostate Cancer in Primary Care

Patients presenting to primary care with prostate symptoms are more likely to be diagnosed with clinically significant prostate cancer than those without recorded symptoms.

Can Deep Brain Stimulation Finally Deliver for Depression?

Nearly a decade ago, a landmark trial of deep brain stimulation for depression failed to show efficacy. Now researchers are trying again, and the stakes are higher than ever.

Imported Eggs Prime Suspect in Salmonella Outbreak

A Salmonella outbreak in the UK has left hundreds ill, with one associated death, and may be linked to imported eggs, say health officials.

Daily Zinc Reduces Infections in Sickle Cell Anemia

Zinc deficiency is common in people with sickle cell disease. Now a trial in Uganda suggests daily supplements can prevent infections in young children with the disease.

Bariatric Same-Day Discharge Criteria Lack Consensus

A systematic review finds that most studies on same-day discharge after bariatric surgery use inconsistent patient selection and discharge definitions, preventing reliable evidence synthesis.

Digital Health: Is Innovation Widening the Equity Gap?

Digital health can improve access, but gaps in technology, digital skills, and infrastructure may leave vulnerable groups behind as adoption expands across healthcare.

Case of a Man With Subclavian Steal Syndrome

A man with arm pain, asymmetric blood pressure, and weakness was found to have overlapping vascular and cervical spine disease complicating the diagnosis.

What Influencers Get Wrong about Diet and Gut Health

Your patients hear these claims online. Here's what the evidence actually shows.

The Challenge of Diagnosing ADHD in Adults

Inattention doesn't necessarily mean ADHD. Dr Zebib Abraham explains the complexities of evaluating adults and what clinicians should consider before making a diagnosis.

Navigating Cancer Screening Without the USPSTF

Without USPSTF guidance, how should primary care approach cancer screening? Dr Kenny Lin reviews key updates in cervical, colorectal, and lung cancer protocols.

Telemedicine Remains Relevant in Pediatric Care

The use of telemedicine in child primary care reduces from pandemic highs to 6% by 2024.

Recommended News For You

Survival rates for incurable larynx cancer investigated for first time

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy

Young adults who are obese are at risk for 17 different types of cancer in the future.

Healthy weight loss could lower your odds for cancer

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

Recommended Articles For You

Case Learning from Acquired Platelet Function Disorders 

Strategic Applications in Hematology in Clinical Decision-Making 

Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology 

Progressive Perspectives in Oncology Across Clinical Settings 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.

2.

Glioblastoma treatment breakthrough shows promise

3.

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

4.

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

5.

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

1.

The Latest Research on Wiskott Aldrich Syndrome 

2.

Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer

3.

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care

4.

Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy 

5.

Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

2.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

3.

Efficient Management of First line ALK-rearranged NSCLC - Part V

4.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

5.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot